We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
-4%
1 Year Est. Return
+80.99%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.26B
AUM Growth
-$362M
Cap. Flow
-$5M
Cap. Flow %
-0.12%
Top 10 Hldgs %
43.71%
Holding
683
New
46
Increased
475
Reduced
93
Closed
17

Top Buys

Rank Stock Value
1
PM icon
Philip Morris
PM
+$38.3M
2
AMZN icon
Amazon
AMZN
+$27.7M
3
PLTR icon
Palantir
PLTR
+$17.5M
4
HIMS icon
Hims & Hers Health
HIMS
+$13.7M
5
YUMC icon
Yum China
YUMC
+$13.2M

Top Sells

Rank Stock Value
1
PDD icon
Pinduoduo
PDD
+$39.4M
2
NVDA icon
NVIDIA
NVDA
+$30.1M
3
META icon
Meta Platforms (Facebook)
META
+$14.9M
4
BEKE icon
KE Holdings
BEKE
+$14.1M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$11.2M

Sector Composition

Rank Sector Weight
1 Technology 42.45%
2 Consumer Discretionary 16.26%
3 Communication Services 14.17%
4 Healthcare 8.06%
5 Consumer Staples 5.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IOVA icon
476
Iovance Biotherapeutics
IOVA
$1.93B
$26K ﹤0.01%
7,805
+1,405
+22% +$7.25K
EMBJ
477
Embraer S.A. ADS
EMBJ
$12.6B
$25.5K ﹤0.01%
+551
New +$24.5K
COLL icon
478
Collegium Pharmaceutical
COLL
$1.15B
$24.7K ﹤0.01%
826
+149
+22% +$4.55K
ELVN icon
479
Enliven Therapeutics
ELVN
$4.15B
$24.6K ﹤0.01%
1,251
+225
+22% +$4.84K
GERN icon
480
Geron
GERN
$821M
$24.6K ﹤0.01%
15,480
+2,787
+22% +$6.79K
NTST
481
NETSTREIT Corp
NTST
$2.08B
$24.5K ﹤0.01%
1,545
+150
+11% +$2.19K
JBGS
482
JBG SMITH
JBGS
$829M
$24.5K ﹤0.01%
1,520
+38
+3% +$578
SYRE icon
483
Spyre Therapeutics
SYRE
$8.24B
$24.2K ﹤0.01%
1,502
+270
+22% +$5.62K
HROW icon
484
Harrow
HROW
$1.46B
$24.2K ﹤0.01%
911
+163
+22% +$4.88K
TXG icon
485
10x Genomics
TXG
$5.97B
$23.9K ﹤0.01%
2,739
+492
+22% +$6.2K
ALEX
486
DELISTED
Alexander & Baldwin
ALEX
$23.7K ﹤0.01%
1,376
+67
+5% +$1.18K
KNSA icon
487
Kiniksa Pharmaceuticals
KNSA
$5.73B
$23.6K ﹤0.01%
1,064
+191
+22% +$3.93K
RLJ icon
488
RLJ Lodging Trust
RLJ
$1.87B
$23K ﹤0.01%
2,909
+92
+3% +$863
PEB icon
489
Pebblebrook Hotel Trust
PEB
$2.18B
$22.9K ﹤0.01%
2,261
+71
+3% +$869
VIR icon
490
Vir Biotechnology
VIR
$1.5B
$22.8K ﹤0.01%
3,526
+634
+22% +$5.64K
XHR
491
Xenia Hotels & Resorts
XHR
$1.89B
$22.5K ﹤0.01%
1,913
+60
+3% +$835
AIV
492
Aimco
AIV
$387M
$22.4K ﹤0.01%
2,542
+244
+11% +$2.17K
GRFS
493
Grifois
GRFS
$5.35B
$22.2K ﹤0.01%
3,123
+561
+22% +$4.23K
GRAL
494
GRAIL Inc
GRAL
$3.02B
$22K ﹤0.01%
860
+161
+23% +$4.97K
ETNB
495
DELISTED
89bio
ETNB
$21.9K ﹤0.01%
3,011
+542
+22% +$4.74K
NRIX icon
496
Nurix Therapeutics
NRIX
$2.41B
$21.6K ﹤0.01%
1,814
+327
+22% +$5.47K
GMAB icon
497
Genmab
GMAB
$17.6B
$21K ﹤0.01%
1,073
+193
+22% +$4.05K
ZYME icon
498
Zymeworks
ZYME
$1.6B
$21K ﹤0.01%
1,763
+317
+22% +$4.32K
XERS icon
499
Xeris Biopharma Holdings
XERS
$1.4B
$21K ﹤0.01%
3,817
+687
+22% +$2.77K
ESRT icon
500
Empire State Realty Trust
ESRT
$850M
$20.9K ﹤0.01%
2,669
+112
+4% +$1.01K
18 19
20
21 22

Similar funds

CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
BP
BC Partners New York $5.96B AUM 15.21% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

GF Fund Management's Q1 2025 Portfolio in Review

As of Q1 2025, GF Fund Management held 683 positions worth $4.26B, down 7.8% from $4.62B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

GF Fund Management's Q1 2025 filing shows 46 new, 475 increased, 93 reduced and 17 closed positions. Its largest new stake was Hims & Hers Health: 368,661 shares worth $10.9M. The largest sale was Pinduoduo, an estimated $39.4M.

By sector, the portfolio is most concentrated in Technology at 42% of assets, down from 45% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • GF Fund Management's largest Q1 2025 buy was Hims & Hers Health: 368,661 shares worth $10.9M.
  • GF Fund Management added most to Philip Morris in Q1 2025, an estimated $38.3M increase.
  • GF Fund Management's biggest Q1 2025 reduction was Pinduoduo, cutting an estimated $39.4M.
  • GF Fund Management fully exited Applied Optoelectronics in Q1 2025, selling an estimated $5.07M.
  • GF Fund Management's ten largest holdings make up 44% of its $4.26B portfolio in Q1 2025.
  • GF Fund Management opened 46 new positions and closed 17 in Q1 2025.
  • GF Fund Management's portfolio value fell 7.8% quarter-over-quarter to $4.26B.

Based on GF Fund Management's 13F filing for Q1 2025, filed 29 Apr 2025.